The report indicates that swift developments are being made within neurotech for uses such as in marketing and wellbeing. The ICO has identified a risk that, if the technology is only tested on a narrow range of individuals, data embedded in it will be incorrect and potentially bias. The ICO has stated that it will present further guidance on this topic shortly.